Astec Lifesciences gains on resuming operations at Dombivili Plant

29 May 2014

Astec Lifesciences is currently trading at Rs. 46.50, up by 0.15 points or 0.32% from its previous closing of Rs. 46.35 on the BSE.

The scrip opened at Rs. 48.50 and has touched a high and low of Rs. 48.50 and Rs. 46.35 respectively. So far 1775 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 48.20 on 25-Apr-2014 and a 52 week low of Rs. 15.60 on 30-Jul-2013.

Last one week high and low of the scrip stood at Rs. 47.90 and Rs. 42.70 respectively. The current market cap of the company is Rs. 86.16 crore.

The promoters holding in the company stood at 58.05% while Non-Institutions held 41.95% stake in the company.

Astec Lifesciences has resumed its manufacturing activities at Dombivili Plant on May 13, 2014 after getting permission from MPCB. Earlier, the company had received order from MPCB for temporary suspension of operations at Dombivili Plant. Astec LifeSciences having its plant at Plot No- F-39, MIDC, Phase II, Dombivili, District- Thane is one of the 22 companies which have received an order for temporary suspension of operations.

National Green Tribunal (NGT) based on an appeal filed by NGO Vanashakti, has been seeking clarifications from MPCB regarding contamination of the Ulhas River.

Astec LifeSciences is a producer of agrochemicals and pharmaceutical intermediates. The company manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates.


Related Astec Lifesciences Ltd. Links:

Astec Lifesciences Share Price

1664.20 29.00 (1.77%) Jan 20, 13:47
1 Year Price Chart
Company Name CMP
UPL 806.25
BASF India 3187.00
PI Industries 2690.05
Bayer CropScience 5059.20
Sumitomo Chemical India 384.70
View more..
Sensex vs Astec Lifesciences